Healthcare
Live Price
Offline$1.70
+6.92% today
1Y Change
-37.28%
Window
Jun 23, 2025 โ Jun 15, 2026
Coverage: 247 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Shandong Weigao Group Medical Polymer Company Limited (SHWGY) is a Healthcare stock with a market cap of $13.36B and listed on OTC. The stock last traded around $1.70 and down 37.3% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -0.5%, EPS growth of -23.9%, a dividend yield of 7.0%. What stands out right now is revenue -0.5%, EPS -23.9%, free cash flow -19.8% with operating margin 14.1% and ROIC 4.9%. The dividend matters to the case here, with a current yield around 7.0%. Valuation is more restrained than many high-expectation growth names at P/E 8.4 and price/sales 1.0. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SHWGY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-0.5% vs +7.6% peer median
Operating Margin
Below sector median
+14.1% vs +19.4% peer median
P/E
Below sector median
8.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 24, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -0.5% and EPS is at -23.9%, with operating margin around 14.1%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 7.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.9% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 24, 2026 | โ | -5.8% | -8.8% | -32.5% |
2025 Sep 1, 2025 | โ | +0.0% | +0.0% | -15.9% |
2025 Mar 24, 2025 | โ | +0.0% | +0.0% | +16.5% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHWGY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SHWGY Max Drawdown
-54.42%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for SHWGY and SPY.

Company Overview
Shandong Weigao Group Medical Polymer Company Limited
Other OTC
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.